journal article·2012-06

Downsizing tumour therapeutics

Christopher J. Cheng, W. Mark Saltzman

Nature Nanotechnology· Volume 7· Issue 6
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Phagocytosis and Immune Regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (7)

Show source-provided references
1. Ruoslahti, E., Bhatia, S. N. & Sailor, M. J. J. Cell Biol. 188, 759–768 (2010).10.1083/jcb.200910104 ↗
2. Matsumura, Y. & Maeda, H. Cancer Res. 46, 6387–6392 (1986).
3. Duggan, S. T. & Keating, G. M. Drugs 71, 2531–2558 (2011).10.2165/11207510-000000000-00000 ↗
4. Fang, J., Nakamura, H. & Maeda, H. Adv. Drug Del. Rev. 63, 136–151 (2011).10.1016/j.addr.2010.04.009 ↗
5. Chauhan, V. et al. Nature Nanotech. 7, 383–388 (2012).10.1038/nnano.2012.45 ↗
6. Jain, R. K. Science 307, 58–62 (2005).10.1126/science.1104819 ↗
7. Alexis, F., Pridgen, E., Molnar, L. K. & Farokhzad, O. C. Mol. Pharm. 5, 505–515 (2008).10.1021/mp800051m ↗